Araştırma Makalesi
BibTex RIS Kaynak Göster

PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE

Yıl 2022, Cilt: 46 Sayı: 3, 955 - 966, 30.09.2022

Nilay Aksoy Nazlı Gül Erdoğan

https://doi.org/10.33483/jfpau.1147465

Öz

Objective: The purpose of this study is to better understand the role of community pharmacists in obesity management by observing their knowledge of weight loss drugs, analyzing their attitudes and behaviors toward patients, and determining their transfer patterns to patients.
Material and Method: After ethical approval, a cross-sectional study was conducted using an online questionnere via a Google online form. The research population consists of community pharmacists working in the province of Kahramanmaraş. The questionnaire was designed to assess Community pharmacists' knowledge and attitudes toward weight loss products. The data was then analyzed using the SPSS for Windows 26.0 program (Statistical Package for Social Sciences).
Result and Discussion: Eighty-six percent of the pharmacists reported always/often counselling customers who request to buy products for weigh management on the safe and effective use of the product and 69.9% always/often check for drug or food interaction while dispensing weight loss products. The majority of Community pharmacists (72.8%) agreed that continuous education of the pharmacist should include weight management and training. Pharmacists surveyed have a moderate knowledge of weight loss products. Time, staff, budget were the barriers to offering pharmacy weight management services. Continuing education, supporting pharmacists with sufficient resources, and conducting more comprehensive research can play a critical role in the fight against obesity.

Anahtar Kelimeler

Community pharmacists knowledge obesity perception weight loss

Destekleyen Kurum

No fund

Kaynakça

  • 1. Hruby, A., Hu, F. B. (2014). The epidemiology of obesity: A big picture. PharmacoEconomics, 33(7), 673–689. [CrossRef]
  • 2. Bhat, S. P., Sharma, A. (2017). Current drug targets in obesity pharmacotherapy – A review. Current Drug Targets, 18(8), 983–993. [CrossRef]
  • 3. Kissane, N. A., Pratt, J. S. (2011). Medical and surgical treatment of obesity. Best practice & research. Clinical anaesthesiology, 25(1), 11–25. [CrossRef]
  • 4. Clements, J. N., Shealy, K. M. (2015). Liraglutide: An injectable option for the management of obesity. The Annals of Pharmacotherapy, 49(8), 938–944. [CrossRef]
  • 5. Whitten, J. S. (2016). Liraglutide (Saxenda) for weight loss. American Family Physician, 94(2), 161-166.
  • 6. Rosenthal, M., Ward, L. M., Teng, J., Haines, S. (2018). Weight management counselling among community pharmacists: A scoping review. The International Journal of Pharmacy Practice, 26(6), 475–484. [CrossRef]
  • 7. Um, I. S., Krass, I., Armour, C., Gill, T., Chaar, B. B. (2015). Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program. International Journal of Clinical Pharmacy, 37(5), 822–833. [CrossRef]
  • 8. Boardman, H. F., Avery, A. J. (2014). Effectiveness of a community pharmacy weight management programme. International Journal of Clinical Pharmacy, 36(4), 800–806. [CrossRef]
  • 9. Gómez-Martinez, J., López-Pintor, E., Lumbreras, B. (2020). Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study. Patient Preference and Adherence, 14, 1501–1511. [CrossRef] 10. Hijazi, M. A., Shatila, H., El-Lakany, A., Al Rifai, H., Aboul-Ela, M., Naja, F. (2020). Role of community pharmacists in weight management: Results of a national study in Lebanon. BMC Health Services Research, 20(1), 386. [CrossRef]
  • 11. AlMukdad, S., Zaghloul, N., Awaisu, A., Mahfoud, Z. R., Kheir, N., El Hajj, M. S. (2021). Exploring the role of community pharmacists in obesity and weight management in Qatar: A Mixed-Methods Study. Risk Management and Healthcare Policy, 14, 2771–2787. [CrossRef]
  • 12. Bates, I., John, C., Bruno, A., Fu, P., Aliabadi, S. (2016). An analysis of the global pharmacy workforce capacity. Human Resources for Health, 14(1), 61. [CrossRef]
  • 13. Newlands, R. S., Watson, M. C., Lee, A. J. (2011). The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: A survey of community pharmacists' attitudes, practice and future possibilities. The International Journal of Pharmacy Practice, 19(2), 106–114. [CrossRef]
  • 14. Fakih, S., Marriott, J. L., Hussainy, S. Y. (2015). A national mailed survey exploring weight management services across Australian community pharmacies. Australian Journal of Primary Health, 21(2), 197–204. [CrossRef]
  • 15. Krska, J., Lovelady, C., Connolly, D., Parmar, S., Davies, M. J. (2010). Community pharmacy contribution to weight management: Identifying opportunities. The International Journal of Pharmacy Practice, 18(1), 7–12. [CrossRef]
  • 16. Lunsford, K. E., Bodzin, A. S., Reino, D. C., Wang, H. L., Busuttil, R. W. (2016). Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. World Journal of Gastroenterology, 22(45), 10071–10076. [CrossRef]
  • 17. Yen, M., Ewald, M. B. (2012). Toxicity of weight loss agents. Journal of medical toxicology: Official journal of the American College of Medical Toxicology, 8(2), 145–152. [CrossRef]
  • 18. Nimptsch, K., Konigorski, S., Pischon, T. (2019). Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism: Clinical and Experimental, 92, 61–70. [CrossRef]
  • 19. Zieck, M., Um, I. S., Chaar, B. B. (2018). The future of weight management in pharmacy education - Perspectives of new generation pharmacists. Currents in Pharmacy Teaching & Learning, 10(5), 596–601. [CrossRef]
  • 20. Awad, A., Waheedi, M. (2012). Community Pharmacists role in obesity treatment in Kuwait: A cross-sectional study. BMC Public Health, 12, 863. [CrossRef]
  • 21. Peletidi, A., Kayyali, R. (2019). Experiences of the pharmacy-led weight management service: Views of service providers in England. Pharmacy, 7(3), 82. [CrossRef]
  • 22. Verma, R. K., Paraidathathu, T., Taha, N. A., Chong, W. W. (2019). Attitudes, practices, and barriers of Malaysian community pharmacists toward provision of weight management services. Frontiers in Pharmacology, 10, 138. [CrossRef]
  • 23. Ahrens, R. A., Hower, M., Best, A. M. (2003). Effects of weight reduction interventions by community pharmacists. Journal of the American Pharmacists Association, 43(5), 583-589. [CrossRef]
  • 24. Clements, J. N., Albanese, N. P., D'Souza, J. J., Misher, A., Reece, S., Trujillo, J., Whitley, H. P. (2021). Clinical review and role of clinical pharmacists in obesity management: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 4(11), 1469-1484. [CrossRef]

TOPLUM ECZACILARININ KİLO VERME ÜRÜNLERİNE KARŞI ALGISI: KAHRAMANMARAŞ İLİ ÖRNEĞİ

Yıl 2022, Cilt: 46 Sayı: 3, 955 - 966, 30.09.2022

Nilay Aksoy Nazlı Gül Erdoğan

https://doi.org/10.33483/jfpau.1147465

Öz

Amaç: Bu çalışmanın amacı, toplum eczacıların kilo verme ilaçları hakkındaki bilgilerini gözlemleyerek, hastalara yönelik tutum ve davranışlarını analiz ederek ve hastalara aktarım şekillerini belirleyerek obezite yönetimindeki rolünü daha iyi anlamaktır.
Gereç ve Yöntem: Etik onaydan sonra, çevrimiçi Google formu aracılığıyla bir anket uygulanarak kesitsel bir çalışma yapılmıştır. Araştırma Kahramanmaraş ilinde çalışan toplum eczacılar üzerinden yürütülmüştür. Anketler, toplum eczacıların zayıflama ürünlerine yönelik bilgi ve tutumlarını değerlendirmek için tasarlanmıştır. Veriler daha sonra Windows 26.0 için SPSS programı (Statistical Package for Social Sciences) kullanılarak analiz edilmilştir.
Sonuçlar ve Tartışma: Yüzde seksen altı, kilo yönetimi için ürün satın almak isteyen müşterilere ürünün güvenli ve etkili kullanımı konusunda her zaman/sıklıkla danışmanlık yaptığını ve %69,9'u zayıflama ürünlerini dağıtırken ilaç-gıda etkileşimini her zaman/sıklıkla kontrol ettiğini bildirdi. toplum Eczacıların çoğunluğu (%72,8) eczacının sürekli eğitiminin kilo yönetimi ve eğitimini içermesi gerektiği konusunda hemfikirdi.
Ankete katılan eczacılar, kilo verme ürünleri hakkında orta düzeyde bilgiye sahipti. Zaman, personel ve bütçe kısıtlılığı, eczacıların kilo yönetimi hizmetleri sunmalarının önünde engeldir. Eczacıların mezun olduktan sonra kilo yönetimi konusunda eğitimlerinin devam etmesi, etkili kilo yönetimi hizmetleri sunmaları için yeterli kaynaklarla eczacıların desteklenmesi ve daha kapsamlı araştırmalar yapılması obezite ile mücadelede kritik rol oynayabilir.

Anahtar Kelimeler

Algı bilgi kilo verme obezite toplum eczacıları

Kaynakça

  • 1. Hruby, A., Hu, F. B. (2014). The epidemiology of obesity: A big picture. PharmacoEconomics, 33(7), 673–689. [CrossRef]
  • 2. Bhat, S. P., Sharma, A. (2017). Current drug targets in obesity pharmacotherapy – A review. Current Drug Targets, 18(8), 983–993. [CrossRef]
  • 3. Kissane, N. A., Pratt, J. S. (2011). Medical and surgical treatment of obesity. Best practice & research. Clinical anaesthesiology, 25(1), 11–25. [CrossRef]
  • 4. Clements, J. N., Shealy, K. M. (2015). Liraglutide: An injectable option for the management of obesity. The Annals of Pharmacotherapy, 49(8), 938–944. [CrossRef]
  • 5. Whitten, J. S. (2016). Liraglutide (Saxenda) for weight loss. American Family Physician, 94(2), 161-166.
  • 6. Rosenthal, M., Ward, L. M., Teng, J., Haines, S. (2018). Weight management counselling among community pharmacists: A scoping review. The International Journal of Pharmacy Practice, 26(6), 475–484. [CrossRef]
  • 7. Um, I. S., Krass, I., Armour, C., Gill, T., Chaar, B. B. (2015). Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program. International Journal of Clinical Pharmacy, 37(5), 822–833. [CrossRef]
  • 8. Boardman, H. F., Avery, A. J. (2014). Effectiveness of a community pharmacy weight management programme. International Journal of Clinical Pharmacy, 36(4), 800–806. [CrossRef]
  • 9. Gómez-Martinez, J., López-Pintor, E., Lumbreras, B. (2020). Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study. Patient Preference and Adherence, 14, 1501–1511. [CrossRef] 10. Hijazi, M. A., Shatila, H., El-Lakany, A., Al Rifai, H., Aboul-Ela, M., Naja, F. (2020). Role of community pharmacists in weight management: Results of a national study in Lebanon. BMC Health Services Research, 20(1), 386. [CrossRef]
  • 11. AlMukdad, S., Zaghloul, N., Awaisu, A., Mahfoud, Z. R., Kheir, N., El Hajj, M. S. (2021). Exploring the role of community pharmacists in obesity and weight management in Qatar: A Mixed-Methods Study. Risk Management and Healthcare Policy, 14, 2771–2787. [CrossRef]
  • 12. Bates, I., John, C., Bruno, A., Fu, P., Aliabadi, S. (2016). An analysis of the global pharmacy workforce capacity. Human Resources for Health, 14(1), 61. [CrossRef]
  • 13. Newlands, R. S., Watson, M. C., Lee, A. J. (2011). The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: A survey of community pharmacists' attitudes, practice and future possibilities. The International Journal of Pharmacy Practice, 19(2), 106–114. [CrossRef]
  • 14. Fakih, S., Marriott, J. L., Hussainy, S. Y. (2015). A national mailed survey exploring weight management services across Australian community pharmacies. Australian Journal of Primary Health, 21(2), 197–204. [CrossRef]
  • 15. Krska, J., Lovelady, C., Connolly, D., Parmar, S., Davies, M. J. (2010). Community pharmacy contribution to weight management: Identifying opportunities. The International Journal of Pharmacy Practice, 18(1), 7–12. [CrossRef]
  • 16. Lunsford, K. E., Bodzin, A. S., Reino, D. C., Wang, H. L., Busuttil, R. W. (2016). Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. World Journal of Gastroenterology, 22(45), 10071–10076. [CrossRef]
  • 17. Yen, M., Ewald, M. B. (2012). Toxicity of weight loss agents. Journal of medical toxicology: Official journal of the American College of Medical Toxicology, 8(2), 145–152. [CrossRef]
  • 18. Nimptsch, K., Konigorski, S., Pischon, T. (2019). Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism: Clinical and Experimental, 92, 61–70. [CrossRef]
  • 19. Zieck, M., Um, I. S., Chaar, B. B. (2018). The future of weight management in pharmacy education - Perspectives of new generation pharmacists. Currents in Pharmacy Teaching & Learning, 10(5), 596–601. [CrossRef]
  • 20. Awad, A., Waheedi, M. (2012). Community Pharmacists role in obesity treatment in Kuwait: A cross-sectional study. BMC Public Health, 12, 863. [CrossRef]
  • 21. Peletidi, A., Kayyali, R. (2019). Experiences of the pharmacy-led weight management service: Views of service providers in England. Pharmacy, 7(3), 82. [CrossRef]
  • 22. Verma, R. K., Paraidathathu, T., Taha, N. A., Chong, W. W. (2019). Attitudes, practices, and barriers of Malaysian community pharmacists toward provision of weight management services. Frontiers in Pharmacology, 10, 138. [CrossRef]
  • 23. Ahrens, R. A., Hower, M., Best, A. M. (2003). Effects of weight reduction interventions by community pharmacists. Journal of the American Pharmacists Association, 43(5), 583-589. [CrossRef]
  • 24. Clements, J. N., Albanese, N. P., D'Souza, J. J., Misher, A., Reece, S., Trujillo, J., Whitley, H. P. (2021). Clinical review and role of clinical pharmacists in obesity management: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 4(11), 1469-1484. [CrossRef]
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Araştırma Makalesi
Yazarlar

Nilay Aksoy 0000-0002-6990-1945

Nazlı Gül Erdoğan 0000-0002-7722-5916

Yayımlanma Tarihi 30 Eylül 2022
Gönderilme Tarihi 23 Temmuz 2022
Kabul Tarihi 25 Ağustos 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 46 Sayı: 3

Kaynak Göster

APA Aksoy, N., & Erdoğan, N. G. (2022). PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE. Journal of Faculty of Pharmacy of Ankara University, 46(3), 955-966. https://doi.org/10.33483/jfpau.1147465
AMA Aksoy N, Erdoğan NG. PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE. Ankara Ecz. Fak. Derg. Eylül 2022;46(3):955-966. doi:10.33483/jfpau.1147465
Chicago Aksoy, Nilay, ve Nazlı Gül Erdoğan. “PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE”. Journal of Faculty of Pharmacy of Ankara University 46, sy. 3 (Eylül 2022): 955-66. https://doi.org/10.33483/jfpau.1147465.
EndNote Aksoy N, Erdoğan NG (01 Eylül 2022) PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE. Journal of Faculty of Pharmacy of Ankara University 46 3 955–966.
IEEE N. Aksoy ve N. G. Erdoğan, “PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE”, Ankara Ecz. Fak. Derg., c. 46, sy. 3, ss. 955–966, 2022, doi: 10.33483/jfpau.1147465.
ISNAD Aksoy, Nilay - Erdoğan, Nazlı Gül. “PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE”. Journal of Faculty of Pharmacy of Ankara University 46/3 (Eylül 2022), 955-966. https://doi.org/10.33483/jfpau.1147465.
JAMA Aksoy N, Erdoğan NG. PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE. Ankara Ecz. Fak. Derg. 2022;46:955–966.
MLA Aksoy, Nilay ve Nazlı Gül Erdoğan. “PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE”. Journal of Faculty of Pharmacy of Ankara University, c. 46, sy. 3, 2022, ss. 955-66, doi:10.33483/jfpau.1147465.
Vancouver Aksoy N, Erdoğan NG. PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE. Ankara Ecz. Fak. Derg. 2022;46(3):955-66.
 Kapak Resmi İndir

Kapsam ve Amaç

Ankara Üniversitesi Eczacılık Fakültesi Dergisi, açık erişim, hakemli bir dergi olup Türkçe veya İngilizce olarak farmasötik bilimler alanındaki önemli gelişmeleri içeren orijinal araştırmalar, derlemeler ve kısa bildiriler için uluslararası bir yayım ortamıdır. Bilimsel toplantılarda sunulan bildiriler supleman özel sayısı olarak dergide yayımlanabilir. Ayrıca, tüm farmasötik alandaki gelecek ve önceki ulusal ve uluslararası bilimsel toplantılar ile sosyal aktiviteleri içerir.